Badoux and colleagues in this issue of Blood report on the use of lenalidomide as first-line treatment of CLL.1 This study appears simple at first glance, but it is remarkable in several respects.
CITATION STYLE
Stilgenbauer, S., & Mertens, D. (2011, September 29). Toward chemotherapy-free treatment of CLL. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-08-367748
Mendeley helps you to discover research relevant for your work.